Literature DB >> 12709434

Lipid-bound structure of an apolipoprotein E-derived peptide.

Vincent Raussens1, Carolyn M Slupsky, Brian D Sykes, Robert O Ryan.   

Abstract

Apolipoprotein (apo) E regulates plasma lipid homeostasis through its ability to interact with the low density lipoprotein (LDL) receptor family. Whereas apoE is not a ligand for receptor binding in buffer alone, interaction with lipid confers receptor recognition properties. To investigate the nature of proposed lipid binding-induced conformational changes in apoE, we employed multidimensional heteronuclear NMR spectroscopy to determine the structure of an LDL receptor-active, 58-residue peptide comprising residues 126-183 of apoE in association with the micelle-forming lipid dodecylphosphocholine (DPC). In the presence of 34 mm DPC the peptide forms a continuous amphipathic helix from Glu131 to Arg178. NMR relaxation studies of DPC-bound apoE-(126-183), in contrast to apoE-(126-183) in the presence of TFE, are consistent with an isotropically tumbling peptide in solution giving a global correlation time of approximately 12.5 ns. These data indicate that the helical peptide is curved and constrained by a lipid micelle consisting of approximately 48 DPC molecules. Although the peptide behaves as if it were tumbling isotropically, spectral density analysis reveals that residues 150-183 have more motional freedom than residues 134-149. These molecular and dynamic features are discussed further to provide insight into the structural basis for the interaction between apoE and the ligand binding repeats of the LDL receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709434     DOI: 10.1074/jbc.M301753200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Direct determination of a membrane-peptide interface using the nuclear magnetic resonance cross-saturation method.

Authors:  Takefumi Nakamura; Hideo Takahashi; Koh Takeuchi; Toshiyuki Kohno; Kaori Wakamatsu; Ichio Shimada
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

Review 2.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

Review 3.  Apolipoprotein E: from lipid transport to neurobiology.

Authors:  Paul S Hauser; Vasanthy Narayanaswami; Robert O Ryan
Journal:  Prog Lipid Res       Date:  2010-09-18       Impact factor: 16.195

4.  Structure of the minimal interface between ApoE and LRP.

Authors:  Miklos Guttman; J Helena Prieto; Tracy M Handel; Peter J Domaille; Elizabeth A Komives
Journal:  J Mol Biol       Date:  2010-03-19       Impact factor: 5.469

5.  Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation.

Authors:  Paul S Hauser; Vincent Raussens; Taichi Yamamoto; Gezman E Abdullahi; Paul M M Weers; Brian D Sykes; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

6.  Solution NMR and CD spectroscopy of an intrinsically disordered, peripheral membrane protein: evaluation of aqueous and membrane-mimetic solvent conditions for studying the conformational adaptability of the 18.5 kDa isoform of myelin basic protein (MBP).

Authors:  David S Libich; George Harauz
Journal:  Eur Biophys J       Date:  2008-05-01       Impact factor: 1.733

Review 7.  Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features.

Authors:  Irina Florina Tudorache; Violeta Georgeta Trusca; Anca Violeta Gafencu
Journal:  Comput Struct Biotechnol J       Date:  2017-06-06       Impact factor: 7.271

8.  Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach.

Authors:  Nicolas Henry; Eva-Maria Krammer; Florian Stengel; Quentin Adams; François Van Liefferinge; Ellen Hubin; Rui Chaves; Rouslan Efremov; Ruedi Aebersold; Guy Vandenbussche; Martine Prévost; Vincent Raussens; Stéphanie Deroo
Journal:  PLoS Comput Biol       Date:  2018-06-22       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.